期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 14, 期 9, 页码 17972-17985出版社
MDPI
DOI: 10.3390/ijms140917972
关键词
aspirin; non-steroidal anti-inflammatory drugs; 5-aminosalicylic acid; cyclooxygenase; prostaglandins; colitis-associated colon cancer; carcinogenesis; Wnt; -catenin; cell cycle; DNA replication fidelity
资金
- Fondazione Umberto di Mario ONLUS, Rome
- AIRC [MFAG-12108, IG-13049]
- Giuliani SpA, Milan, Italy
Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide. Although conclusive evidence is still lacking, epidemiologic studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) has chemopreventive properties against CRC. Similarly, regular consumption of mesalazine, a drug structurally related to NSAIDs, seems to reduce the risk of CRC in patients with ulcerative colitis. These observations are supported by a large body of experimental data showing the ability of such drugs to inhibit multiple pathways that sustain colon carcinogenesis. This review summarizes the current information on the molecular mechanisms by which NSAIDs and mesalazine could interfere with CRC cell growth and survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据